Veterinary Medicines

Panacur PetPaste 187.5 mg/g oral paste for dogs and cats

Authorised
  • Fenbendazole
Download as PDF

Product identification

Medicine name:
Panacur PetPaste 187.5 mg/g oral paste for dogs and cats
Active substance:
  • Fenbendazole
Target species:
  • Dog
  • Cat
Route of administration:
  • Oral use

Product details

Active substance and strength:
  • Fenbendazole
    187.50
    milligram(s)
    /
    1.00
    gram(s)
Pharmaceutical form:
  • Oral paste
Withdrawal period by route of administration:
  • Oral use
    • Dog
    • Cat
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QP52AC13
Legal status of supply:
  • Veterinary medicinal product not subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • Luxembourg
Package description:
  • (ID2) 48 gram(s): unspecified outer container with 10 Applicator each with 4.8 gram(s)
  • (ID1) 4.8 gram(s): unspecified outer container with 1 Applicator with 4.8 gram(s)

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Full application (Article 12(3) of Directive No 2001/82/EC)
Marketing authorisation holder:
  • Intervet International B.V.
Marketing authorisation date:
Manufacturing sites for batch release:
  • Intervet Productions S.A.
Responsible authority:
  • Ministry Of Health
Authorisation number:
  • V 817/05/05/0826
Date of authorisation status change:
Reference member state:
  • Germany
Procedure number:
  • DE/V/0109/001
Concerned member states:
  • Austria
  • Belgium
  • Czechia
  • Denmark
  • Greece
  • Hungary
  • Ireland
  • Luxembourg
  • Netherlands
  • Portugal
  • Spain

Documents

Combined File of all Documents

English (PDF)
Published on: 14/02/2024
Download
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."